ZNTLNasdaq GM

Zentalis Pharmaceuticals, Inc.

3.88+3.19%1d

Data as of Aug 25, 2026 · end-of-day snapshot

Volume signal tierC
Alert levelBaseline

Tier and alert level are a summary. Unlock ZNTL to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.

+5.43%, upReturn · 1w
−13.97%, downReturn · 1m
−3.48%, downReturn · 3m
+113.19%, upReturn · 1y
−44.17%, well below its 52-week highvs 52-week high
Technicals

Technical readings

The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.

Automated read

The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 41.

RSI (14)40.59, caution readingLower-neutral
MACD / signal-0.21 / -0.13, caution readingBelow signal line
SMA 504.33, caution readingPrice below
SMA 2003.13, favorable readingPrice above
EMA 204.16, caution readingPrice below
ADX (14)18.78Rangebound
+DI / −DI19.26 / 26.65−DI leading
ATR (14)0.32, flagged reading8.2% of price — elevated daily swings
Stochastic %K20.18Mid-range
Bollinger bands (20)3.37 – 5.26Inside bands
ROC (10)-9.36, caution readingNegative over 10 sessions
Trend / momentum impulseMixedTrend and momentum disagree

Readings as of Aug 25, 2026 · end-of-day snapshot

Full analysis

What unlocking ZNTL reveals

Sample preview: figures are illustrative.

Company & theme write-up

Signal history

AI narrative

Catalysts & risks

Accumulation read

Unlock ZNTL: full analysis
Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get ZNTL + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
$9.90one-time Unlock ZNTL